Point of View

    The Science Is Never the Problem.

    Ninety percent of diagnostic technologies that clear validation never achieve sustainable adoption. The science works. The clinical data exists. Yet these innovations stall in the gap between the laboratory and the clinic.

    View Our Framework

    The Commercialization Gap

    Diagnostics Does Not Have a Science Problem. It Has a Commercialization Problem.

    The cause is structural, not scientific. Evidence generation, regulatory strategy, reimbursement pathways, and market placement are treated as isolated silos. Each one optimized independently. None connected to a unified commercial outcome.

    This pattern repeats across the diagnostic industry. Not because the science is weak, but because commercialization architecture is defined too late, or never defined at all.

    Evidence Generation

    Regulatory Strategy

    Reimbursement Pathways

    Market Placement

    Integrated Commercial Architecture

    Evidence aligned to payer logic

    Regulatory pathway validated

    Reimbursement codes mapped

    Channel architecture defined

    Launch sequence staged

    Stakeholder narrative built

    Our Mission

    Architect diagnostic innovation toward adoption through commercial infrastructure designed for sustainable revenue.

    We do not just offer advice. We engineer the structural integrity of your launch. By fusing disparate clinical and commercial requirements into a single, load bearing roadmap, we ensure your innovation achieves adoption.

    Methodology

    Why Architecture, Not Consulting.

    Traditional consulting delivers recommendations. Architecture delivers infrastructure. The difference is the gap between a strategy deck and a functioning commercial system.

    Our methodology sequences six decision layers, each resolving before the next begins, so commercial investment lands on structure rather than assumption.

    The result: diagnostic companies that launch with the operating model, pricing architecture, and channel logic already validated, not retroactively assembled after clearance.

    The Six Layers

    01Market and Category Strategy

    Defining the market you will own and the category position that drives adoption.

    02Evidence and Adoption Strategy

    Aligning clinical and economic data to payer and physician decision logic.

    03Channel and Distribution Architecture

    Designing the distribution pathway that matches your product to its buyer.

    04Reimbursement and Access Strategy

    Building the coverage and coding foundation that unlocks sustainable revenue.

    05Launch Sequencing and Field Strategy

    Staging market entry so every resource compounds toward early traction.

    06Stakeholder and Investor Alignment

    Ensuring your commercial story holds up to diligence from funders and partners.

    Institutional Foundation

    Institutional Access. Channel Authority. Field Credibility.

    Built over 20+ years inside the diagnostic ecosystem, beginning in 2002.

    Institutional Access

    Engagement across federal health systems, state public health laboratories, and large integrated delivery networks.

    Channel Authority

    Designed and led national distributor architecture across acute and decentralized markets, including category alignment, field enablement, and launch sequencing.

    Field Credibility

    Led regional and national field sales organizations driving molecular and point-of-care adoption across complex care environments.

    Acute Hospital Laboratories·Point-of-Care Settings·Consumer and OTC Diagnostics·State Public Health Laboratories·Federal Health Systems

    Operator Experience

    Operator experience across the diagnostic lifecycle.

    01

    Evidence Strategy

    • Designed clinical study frameworks aligned to payer and physician decision logic
    • Built evidence narratives connecting analytical performance to clinical utility
    • Guided CRO selection, site sourcing, and predicate strategy for 510(k) submissions

    02

    Launch Architecture

    • Architected go to market operating models from pre clearance through first revenue
    • Built pricing frameworks grounded in reimbursement reality, not aspiration
    • Designed launch sequencing across customer segments, geographies, and care settings

    03

    Channel & Distribution Design

    • Led national distributor strategy, selection, and onboarding for new diagnostic platforms
    • Built category positioning and listing strategy for major distribution partners
    • Designed channel economics and incentive structures that align with adoption goals

    04

    Adoption and Scale

    • Installed placement operating models that converted first use into repeatable utilization
    • Built physician engagement and clinical narrative delivery systems
    • Designed utilization tracking infrastructure to identify drop off and drive retention

    Work with an operator.

    Your diagnostic platform deserves a commercial model built to match it. Let us build it together.

    In a confidential 30 minute session, we will review your current stage and identify the single most critical commercial risk to address before your next funding or launch milestone.